Cargando…

The Use of Virtual Care in Patients with Hematologic Malignancies: A Scoping Review

There is increasing interest from cancer patients and their healthcare providers in the use of virtual care in routine clinical practice. In the setting of hematologic malignancy, where patients often undergo complex and immunodepleting treatments, understanding how to use virtual care safely and ef...

Descripción completa

Detalles Bibliográficos
Autores principales: Suleman, Adam, Vijenthira, Abi, Berlin, Alejandro, Prica, Anca, Rodin, Danielle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8871074/
https://www.ncbi.nlm.nih.gov/pubmed/35200575
http://dx.doi.org/10.3390/curroncol29020076
_version_ 1784656909473677312
author Suleman, Adam
Vijenthira, Abi
Berlin, Alejandro
Prica, Anca
Rodin, Danielle
author_facet Suleman, Adam
Vijenthira, Abi
Berlin, Alejandro
Prica, Anca
Rodin, Danielle
author_sort Suleman, Adam
collection PubMed
description There is increasing interest from cancer patients and their healthcare providers in the use of virtual care in routine clinical practice. In the setting of hematologic malignancy, where patients often undergo complex and immunodepleting treatments, understanding how to use virtual care safely and effectively is critically important. We aimed to describe the use of virtual care in patients with hematologic malignancies and to examine physician- and patient-reported outcomes in the form of a systematic scoping review. An electronic search of PubMed, Ovid MEDLINE, Elsevier Embase, Scopus, and EBSCO CINAHL was conducted from January 2000 to April 2021. A comprehensive search strategy was used to identify relevant articles, and data were extracted to assess the study design, population, setting, patient characteristics, virtual care platform, and study results. Studies were included if they described the use of virtual care for patients with hematologic malignancies; commentaries were excluded. Fifteen studies met the inclusion criteria after abstract and full-text review. Three studies found that app-based tools were effective in monitoring patient symptoms and triggering alerts for more urgent follow-up. Four studies described the use of phone-based interventions. Five studies found that videoconferencing, with both physicians and oncology nurses, was highly rated by patients. Emerging themes included high levels of patient satisfaction across all domains of virtual care. Provider satisfaction scores were rated lower than patient scores, with concerns about technical issues leading to challenges with virtual care. Four studies found that virtual care allowed providers to promptly respond to patient concerns, especially when patients were experiencing side-effects or had questions about their treatment. Overall, the use of virtual care in patients with hematologic malignancies appears feasible, and resulted in high patient satisfaction. Further research is needed in order to evaluate the optimal method of integrating virtual care into clinical practice.
format Online
Article
Text
id pubmed-8871074
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-88710742022-02-25 The Use of Virtual Care in Patients with Hematologic Malignancies: A Scoping Review Suleman, Adam Vijenthira, Abi Berlin, Alejandro Prica, Anca Rodin, Danielle Curr Oncol Review There is increasing interest from cancer patients and their healthcare providers in the use of virtual care in routine clinical practice. In the setting of hematologic malignancy, where patients often undergo complex and immunodepleting treatments, understanding how to use virtual care safely and effectively is critically important. We aimed to describe the use of virtual care in patients with hematologic malignancies and to examine physician- and patient-reported outcomes in the form of a systematic scoping review. An electronic search of PubMed, Ovid MEDLINE, Elsevier Embase, Scopus, and EBSCO CINAHL was conducted from January 2000 to April 2021. A comprehensive search strategy was used to identify relevant articles, and data were extracted to assess the study design, population, setting, patient characteristics, virtual care platform, and study results. Studies were included if they described the use of virtual care for patients with hematologic malignancies; commentaries were excluded. Fifteen studies met the inclusion criteria after abstract and full-text review. Three studies found that app-based tools were effective in monitoring patient symptoms and triggering alerts for more urgent follow-up. Four studies described the use of phone-based interventions. Five studies found that videoconferencing, with both physicians and oncology nurses, was highly rated by patients. Emerging themes included high levels of patient satisfaction across all domains of virtual care. Provider satisfaction scores were rated lower than patient scores, with concerns about technical issues leading to challenges with virtual care. Four studies found that virtual care allowed providers to promptly respond to patient concerns, especially when patients were experiencing side-effects or had questions about their treatment. Overall, the use of virtual care in patients with hematologic malignancies appears feasible, and resulted in high patient satisfaction. Further research is needed in order to evaluate the optimal method of integrating virtual care into clinical practice. MDPI 2022-02-07 /pmc/articles/PMC8871074/ /pubmed/35200575 http://dx.doi.org/10.3390/curroncol29020076 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Suleman, Adam
Vijenthira, Abi
Berlin, Alejandro
Prica, Anca
Rodin, Danielle
The Use of Virtual Care in Patients with Hematologic Malignancies: A Scoping Review
title The Use of Virtual Care in Patients with Hematologic Malignancies: A Scoping Review
title_full The Use of Virtual Care in Patients with Hematologic Malignancies: A Scoping Review
title_fullStr The Use of Virtual Care in Patients with Hematologic Malignancies: A Scoping Review
title_full_unstemmed The Use of Virtual Care in Patients with Hematologic Malignancies: A Scoping Review
title_short The Use of Virtual Care in Patients with Hematologic Malignancies: A Scoping Review
title_sort use of virtual care in patients with hematologic malignancies: a scoping review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8871074/
https://www.ncbi.nlm.nih.gov/pubmed/35200575
http://dx.doi.org/10.3390/curroncol29020076
work_keys_str_mv AT sulemanadam theuseofvirtualcareinpatientswithhematologicmalignanciesascopingreview
AT vijenthiraabi theuseofvirtualcareinpatientswithhematologicmalignanciesascopingreview
AT berlinalejandro theuseofvirtualcareinpatientswithhematologicmalignanciesascopingreview
AT pricaanca theuseofvirtualcareinpatientswithhematologicmalignanciesascopingreview
AT rodindanielle theuseofvirtualcareinpatientswithhematologicmalignanciesascopingreview
AT sulemanadam useofvirtualcareinpatientswithhematologicmalignanciesascopingreview
AT vijenthiraabi useofvirtualcareinpatientswithhematologicmalignanciesascopingreview
AT berlinalejandro useofvirtualcareinpatientswithhematologicmalignanciesascopingreview
AT pricaanca useofvirtualcareinpatientswithhematologicmalignanciesascopingreview
AT rodindanielle useofvirtualcareinpatientswithhematologicmalignanciesascopingreview